|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> 柏替木单抗>> 市场分析报告 |
柏替木单抗市场分析报告 |
|
Global Market Report of Bertilimumab (CAS 375348-49-5) December 2024 CAS 375348-49-5 Bertilimumab Chemical Report & Database ... listed. The substance covered (Bertilimumab) are classified by the Chemical ... Report & Database definitions: Name: Bertilimumab: Bertilimumab Chemical Registry number: 769198057210 ... : Chemical or Reaction Intermediate The Bertilimumab Report & Database gives Market ... Bullous Pemphigoid Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Bullous Pemphigoid Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bullous Pemphigoid - Drugs In Development, 2022, ... Global Allergic Conjunctivitis Market, Patients, Treated Patients, by Countries (India, China, Japan, US, UK, etc), Disease Type (SAC, PAC, VKC, AKC, GPC), Drugs Profile (Zerviate, OTX-DP, ADX-102, PRT-2761, etc) Companies, Growth Drivers & Challenges ... , PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011) Companies ... , PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011 etc ... PRT-2761 CVXL-0074 AK-002 Bertilimumab Reproxalap ST-266 SYL-116011 Company ... Vernal Keratoconjunctivitis - Pipeline Insight, 2021 ... iCo-008: iCo Therapeutics Bertilimumab is a fully human monoclonal antibody ... resulted in three clinical studies of bertilimumab conducted in EU (a total of 126 ... of good safety and tolerability of bertilimumab when administered by the intravenous (IV ... Allergic Conjunctivitis Market, Global Forecast Treated Patients By Countries, Disease Type, Pipeline Drugs, Company Analysis ... , PRT-2761, CVXL-0074, AK-002, Bertilimumab, Reproxalap, ST-266, SYL-116011) Companies ... PRT-2761 CVXL-0074 AK-002 Bertilimumab Reproxalap ST-266 SYL-116011 All ... Allergic Conjunctivitis - Pipeline Review, H1 2020 Allergic Conjunctivitis - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Conjunctivitis - Pipeline Review, H1 2020, provides an overview of the Allergic Conjunctivitis ( ... Targeted Therapies in Asthma: KOL Insight [2018] ... 7195 (anti-IgE/CD32b; Xencor) Bertilimumab (anti-CCL11 chemokine; Immune Pharmaceuticals ... Bullous pemphigoid - Pipeline Insight, 2021 ... Products Benralizumab Dupilumab Lazucirnon Nomacopan Bertilimumab Ixekizumab Apremilast Diacerein Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Allergic Conjunctivitis - Drugs In Development ... |